Pharma distribution directory 2026

    Pharmaceutical Distributors in Saudi Arabia

    Saudi Arabia moves medicines through two very different pipes: a single government buyer (NUPCO) that tenders for Ministry of Health and most public hospitals, and a handful of family-owned import agents that hold the exclusive SFDA marketing authorisation for foreign brands and sell them into private hospitals and the 10,000-plus community pharmacies.

    The directory below lists the distributors, agents and logistics partners a pharma or consumer-health brand actually deals with in the Kingdom. It is organised the way a market-entry or channel-audit brief is organised: who holds the licence, who physically ships, who invoices which channel, and where the public and private routes diverge. Company classification reflects ownership and role, not turnover.

    Updated September 2026 · Saudi Food and Drug Authority (SFDA) — licensed drug establishments and importers register as of September 2026 · 17 named accounts

    Request a proposal for Saudi ArabiaBrowse the 17 companies

    $11bn+

    Saudi pharmaceutical market, 2024 estimate

    ~60%

    Share of drug spend routed through public procurement

    10,000+

    Licensed community pharmacies

    1

    Central public buyer for MOH tenders (NUPCO)

    Named accounts

    Top pharmaceutical distributors in Saudi Arabia

    Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against Saudi Food and Drug Authority (SFDA) — licensed drug establishments and importers register (as of 2026-09-03).
    #CompanyHQ
    01NUPCO (National Unified Procurement Company)Riyadh
    02Cigalah GroupJeddah
    03Banaja HoldingsJeddah
    04Tamer GroupJeddah
    05Salehiya MedicalRiyadh
    06Abdulrehman Algosaibi GTCRiyadh
    07Alhaya Medical CompanyRiyadh
    08MEDISERV (Medical Supplies & Services Co.)Riyadh
    09Gulf Medical CompanyJeddah
    10Abdulla Fouad Health ServicesDammam
    11Bait Al Batterjee MedicalJeddah
    12Arabian Health Care Supply Company (AHCS)Riyadh
    13Al Amin Medical InstrumentsRiyadh
    14Al Faisaliah Medical SystemsRiyadh
    15DHL Supply Chain Saudi ArabiaRiyadh
    16Almajdouie LogisticsDammam
    17Naqel ExpressRiyadh

    Primary research

    These are the distributors and wholesalers we map in Saudi Arabia

    Choosing or auditing a distribution partner in Saudi Arabia? BioNixus runs distributor due-diligence interviews, channel-share estimates and pharmacy-level availability checks. Proposal ready within 48 hours of a brief.

    Planning research in Saudi Arabia?

    Primary research, market access & HEOR. A 30-minute scoping call, then a costed proposal within 48 hours.

    What happens on the call

    • We pin down the decision your research has to support.
    • We check feasibility: respondent types, countries and timeline.
    • You receive a costed proposal within 48 hours of the call.

    Top market research companies in Saudi Arabia (2026)

    How the market is structured

    How pharmaceutical distribution works in Saudi Arabia

    A foreign manufacturer cannot sell directly in the Kingdom. It appoints a Saudi agent, and that agent registers the product with the SFDA, holds the import licence and becomes the legal marketing authorisation holder. For the public channel the agent bids into NUPCO tenders and then delivers to NUPCO warehouses or directly to hospital stores. For the private channel the same agent sells to private hospital groups, to the two national pharmacy chains (Nahdi and Al-Dawaa) that together control roughly a third of retail counters, and to independent pharmacies through regional wholesale depots. Cold-chain biologics increasingly move through specialised 3PLs that the agent subcontracts. Local manufacturers such as SPIMACO, Jamjoom and Tabuk run their own sales forces but still rely on the same wholesale depots for pharmacy reach outside Riyadh, Jeddah and Dammam.

    Local

    Saudi-owned agents that hold SFDA marketing authorisations for foreign brands and own the customer relationship with hospitals and pharmacies. Almost every launch in the Kingdom passes through one of them.

    • Cigalah Group
    • Banaja Holdings
    • Tamer Group
    • Salehiya Medical
    • Abdulrehman Algosaibi GTC
    • Alhaya Medical Company
    • MEDISERV (Medical Supplies & Services Co.)
    • Abdulla Fouad Health Services
    • Bait Al Batterjee Medical
    • Arabian Health Care Supply Company (AHCS)
    • Al Amin Medical Instruments
    • Al Faisaliah Medical Systems

    Multinational

    Global logistics operators that provide GDP-compliant warehousing and cold chain but do not hold product licences. They are subcontracted by agents rather than appointed by manufacturers.

    • DHL Supply Chain Saudi Arabia

    Regional

    Gulf-wide trading groups able to represent a brand in Saudi Arabia and neighbouring markets under one contract, trading depth of coverage for simplicity.

    • Gulf Medical Company

    Wholesalers, importers & 3PL

    The public buyer, provider-linked wholesalers and specialist 3PL and last-mile carriers that physically move product from port to hospital store or pharmacy shelf.

    • NUPCO (National Unified Procurement Company)
    • Almajdouie Logistics
    • Naqel Express

    What is moving

    What is moving pharma distribution in Saudi Arabia

    NUPCO centralisation and the Health Holding Company clusters

    As MOH hospitals move into regional health clusters under the Health Holding Company, NUPCO tender volumes and delivery specifications keep changing. Agents with tender desks and buffer stock win; those relying on hospital-by-hospital selling lose share.

    Localisation targets under Vision 2030

    The SFDA and Ministry of Industry favour locally manufactured or locally packaged products in tenders. Distributors are forming contract-packaging and toll-manufacturing ventures so their principals qualify for local-content preference.

    Pharmacy consolidation and e-pharmacy

    Nahdi and Al-Dawaa negotiate directly with agents and increasingly bypass regional wholesalers. Wasfaty e-prescriptions and pharmacy delivery apps have made last-mile capability part of the distributor pitch.

    Cold-chain biologics and specialty

    Oncology, immunology and GLP-1 volumes are pushing agents to validate cold rooms and reefers or to subcontract to DHL, Almajdouie and similar 3PLs, changing the margin structure of distribution.

    BioNixus fieldwork

    How BioNixus studies pharmaceutical distributors in Saudi Arabia

    The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in Saudi Arabia:
    • Distributor due diligence: 20–40 interviews with hospital purchasers and pharmacy owners on service levels, credit terms and delivery reliability by agent.
    • Share-of-wholesaler estimates by region (Central, Western, Eastern) for a defined basket of SKUs, from pharmacy purchase-record audits.
    • NUPCO tender landscaping: which agents bid, at what price bands, and how award patterns shifted after cluster reorganisation.
    • Cold-chain readiness audits for biologics launches, covering validated storage, reefer capacity and last-mile handling.

    Pharmaceutical Distributors market research in Saudi Arabia

    Questions

    Frequently Asked Questions

    Can a foreign pharmaceutical company sell directly in Saudi Arabia?

    Not in practice. Imported medicines must be registered with the SFDA by a licensed Saudi establishment that acts as the marketing authorisation holder and importer. Foreign companies may open a scientific office to promote products, but the commercial and regulatory chain runs through an appointed Saudi agent or distributor.

    Who is the largest pharmaceutical buyer in Saudi Arabia?

    NUPCO, the National Unified Procurement Company, which centralises purchasing for the Ministry of Health and most government hospital systems. Winning or losing a NUPCO tender can move a brand’s national volume more than any private-sector account.

    How do distributors reach community pharmacies outside the big cities?

    Through regional wholesale depots in Riyadh, Jeddah and Dammam and, increasingly, through the chains’ own distribution centres. Nahdi and Al-Dawaa self-distribute to their stores; independents are served by agents’ regional branches or by sub-wholesalers.

    Do Saudi distributors handle cold-chain biologics?

    The large agents do, either through validated in-house cold rooms or by subcontracting to GDP-certified 3PLs such as DHL Supply Chain and Almajdouie. Smaller agents typically rely entirely on 3PL partners for temperature-controlled lines.

    What does BioNixus study about pharmaceutical distributors in Saudi Arabia?

    Distributor due-diligence interviews with hospital pharmacists and purchasers, share-of-wholesaler estimates by pharmacy region, service-level benchmarking (fill rate, delivery frequency, credit terms) and tender-outcome tracking. Fieldwork is bilingual and account-level, so the output names the accounts rather than averaging the market.

    Is this list a ranking of the best distributors?

    No. It is an editorial directory of the distributors, agents and logistics partners BioNixus encounters most often in Saudi fieldwork, checked against the SFDA establishment register. Order and inclusion do not indicate size or quality.

    Sources

    Data sources & methodology

    This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Saudi Arabia. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

    Primary register: Saudi Food and Drug Authority (SFDA) — licensed drug establishments and importers register, consulted 2026-09-03. Company classification (Local / MNC / Regional / wholesalers, importers & 3pl) reflects ownership and role in Saudi Arabia, not size.

    • NUPCO corporate disclosures and tender portal (nupco.com), 2025–2026
    • General Authority for Statistics (GaStat) health facility counts and SFDA pharmacy licensing statistics, 2024–2025
    • IQVIA and company annual reports for Saudi market-size estimates, 2024
    • BioNixus Saudi hospital and retail pharmacy fieldwork, 2024–2026

    BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

    48-hour proposal

    Need distributor and channel data in Saudi Arabia?

    Coverage, credit terms, cold-chain capability and share of pharmacy purchases by wholesaler — from the pharmacies and hospitals themselves, not a directory.

    Planning research in Saudi Arabia?

    Primary research, market access & HEOR. A 30-minute scoping call, then a costed proposal within 48 hours.

    What happens on the call

    • We pin down the decision your research has to support.
    • We check feasibility: respondent types, countries and timeline.
    • You receive a costed proposal within 48 hours of the call.